Geode Capital Management, LLC Transcode Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.31 - $0.91 $268 - $788	-866 Reduced 1.13%	75,683 $25,000
Q2 2022 Aug 12, 2022	BUY	$1.2 - $3.03 $6,332 - $15,989	5,277 Added 7.4%	76,549 $96,000
Q4 2021 Feb 11, 2022	BUY	$2.42 - $3.41 $131,282 - $184,989	54,249 Added 318.68%	71,272 $181,000
Q3 2021 Nov 12, 2021	BUY	$2.37 - $6.45 $40,344 - $109,798	17,023 New	17,023 $50,000

6.5K

Ticker RNAZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,977,200
Market Cap $45.7M
Description
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs incl...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.